TB-500 Community Reports
What do these badges mean?
Evidence tier
- AHuman-validated — Human trials showing positive results and good safety.
- BAnimal-grade — No human trials yet, but solid animal/preclinical evidence of effect and safety.
- CAnecdotal — No human or animal trials — only anecdotal/observational reports.
- DInsufficient evidence — No or insufficient evidence (encyclopedia only — never recommended by the builder).
Safety light
- 🟢 Green — Only mild, manageable side effects; reasonable safety data.
- 🟡 Yellow — Needs active management, has a meaningful contraindication/interaction, or has thin long-term data.
- 🔴 Red — Risk of a hospital-level event — treat with serious caution.
Browse-only — not on the protocol builder's curated shortlist, so the builder won't recommend it.
How can it help me?
Wiki article — community perspective
Companion raw digest:
Evidence tier: throughout
Last updated: 2026-07-10
Cross-refs: *peptides/bpc-157* · *peptides/wolverine-blend* · *peptides/glow-blend* · *peptides/klow-blend*
The full evidence — every human, animal, and lab study, graded — is one tap away: use the See the deeper science → toggle at the top.
Typical dosing
Talk to your medical provider before starting any protocol. That said, here are the doses most people commonly use — shared for educational purposes so you can have an informed conversation. These peptides are sold for research use only and are not FDA-approved drugs, and this isn't medical advice.
What should I avoid combining — and what's synergistic?
TB-500 Community Reports doesn't have a dedicated stacking protocol in our notes — the interactions that matter most are in the safety section above. For how people combine it with other peptides, the deeper-science view has the full detail.
How can I buy this?
We don't have a verified affiliate source for TB-500 Community Reports yet, so there's no coupon or vendor link here — we won't point you to a seller we haven't vetted. When buying any research-use-only peptide, the single biggest variable is the supply chain: insist on a vendor that publishes third-party Certificates of Analysis (COAs) confirming identity and >99% purity. Working with a peptide-literate clinician is one solid route — see our provider directory — or check back as our verified sources list grows.
Wiki article — community perspective
Companion raw digest:
Evidence tier: throughout
Last updated: 2026-07-10
Cross-refs: *peptides/bpc-157* · *peptides/wolverine-blend* · *peptides/glow-blend* · *peptides/klow-blend*
Who reports the strongest results
One category dominates: people with chronic, treatment-resistant soft-tissue injuries. Rotator cuffs, Achilles tendons, patellar tendons, bicep tears, muscle tears, plantar fascia — injuries that haven’t responded to physical therapy, PRP, corticosteroids, or rest. TB-500’s community reputation is built on doing what conventional treatment couldn’t: driving structural repair in tissue that had stopped healing.
The pattern that repeats: “I’d had this [shoulder / knee / Achilles] injury for [6 months / 2 years / 7 years], tried everything, and TB-500 was what finally moved it.”
What the community actually says
Healing vs pain relief — the distinction that matters
Users don’t describe pain relief. They describe healing. The community-level distinction is explicit and important: TB-500 is not an analgesic. The mechanism described is actual tissue remodeling over weeks.
- Pain reduction typically noticeable by weeks 1–2
- Functional return (strength, range of motion) comes later — weeks 4–6 during loading
- Consistent community warning: “Pain drops faster than structural integrity returns — don’t rush back to full training” — this exact framing appears across threads from multiple communities and injury types
Less conventional applications that appear consistently
Two applications recur often enough across forums to note:
- Eye floater reduction — partial resolution documented across multiple user accounts; mechanism proposed as angiogenesis improving ocular vasculature; unconfirmed
- Chronic fissure healing — at least one detailed log documents healing a chronic anal fissure unresponsive to standard treatment
Protocol as used by the community
Loading phase: 2–2.5 mg SubQ or IM, twice per week, for 4–6 weeks
Maintenance phase: 1–2 mg per week for 4–8 additional weeks
Half-life estimate: Community pegs this at 5–7 days — drives the twice-weekly loading frequency to maintain tissue saturation during acute healing.
Injection approach — the local vs systemic debate: Community is divided but not strongly. Systemic SubQ injection (abdomen) is more common for convenience and diffuse injuries. Some users inject near the injury site for concentrated local effect. No clear consensus on superiority. For multiple or hard-to-pinpoint injuries, systemic is recommended.
Pairing with BPC-157 (the Wolverine stack):
TB-500 and BPC-157 are viewed as complementary — TB-500 for systemic/diffuse soft-tissue repair and muscle; BPC-157 for tendons, nerves, and gut with stronger local injection data. Together they cover more ground than either alone. See *peptides/wolverine-blend*.
Side effects and risk signals
Side effect profile is generally mild.
- Lethargy early in cycles (resolves within 1–2 weeks)
- Headache occasional; dose-dependent
- Temporary pain flare at injury site first 1–2 weeks — experienced users interpret as biological activity, not damage
- Injection site redness and mild swelling (standard peptide injection)
Cancer / angiogenesis concern (theoretical): TB-500 promotes angiogenesis (new blood vessel formation). Theoretical concern: could also support growth of pre-existing tumors. No confirmed cases in community use; the mechanism is real but the risk to healthy users is unquantified. Community consensus is clear: not appropriate for anyone with known or suspected malignancy. Flag this for users who raise the question.
WADA S0 ban: Prohibited for tested athletes. Non-tested users are unaffected by this classification.
Non-response: ~40% and why
About 40% of users report no meaningful effect. In order of how often each cause is cited:
- Product quality — the most common attributed cause; purity and actual peptide content vary enormously across suppliers
- Underdosing during loading — the 2–2.5 mg twice-weekly loading dose matters; cutting it to save cost correlates with non-response
- Wrong injury type — TB-500 is a soft-tissue peptide; expectations of bone repair or purely articular cartilage healing are frequently disappointed
- Stopping too early — some users quit before completing the 4–6 week loading phase
Frequently asked questions (community version)
TB-500 vs BPC-157 — which for which injury? Community rules of thumb: BPC-157 for gut issues, nerve damage, tendons with local injection; TB-500 for diffuse/systemic soft tissue, muscle tears, cardiorespiratory function. Wolverine stack (both) is the community gold standard for serious musculoskeletal injuries.
Does the WADA ban affect me? Only if you compete in a WADA-tested sport. For recreational users and non-tested athletes, the classification has no practical effect on legality or use.
Is the cancer concern real? The angiogenic mechanism is real. The risk to otherwise healthy people is theoretical and unquantified in practice. Community consensus: acknowledged as a legitimate signal; not seen as prohibitive for healthy users; an absolute contraindication for anyone with known or suspected malignancy.
Where should I inject — near the injury or systemically? Both approaches report success. For a defined single-site injury, some prefer local injection. For diffuse injuries or multiple sites, systemic SubQ is simpler and reportedly effective. No strong evidence base for either being universally superior.
Notable community accounts
- cdoubleu (MESO-Rx): 7-year chronic shoulder injury unresponsive to PT and PRP; 6-week loading protocol; pain substantially reduced by week 4; returned to weight training by week 8
- Gigantic (forum): Chronic anal fissure resolved after SubQ TB-500 loading — documented as example of systemic reach beyond musculoskeletal application
- Rokslide hunting/athletics community: Multiple accounts of knee, shoulder, and Achilles recovery enabling return to hunting and climbing after a year+ of failed conventional treatment
Cross-references
*peptides/bpc-157*— most natural pairing; the other half of the Wolverine stack*peptides/wolverine-blend*— BPC-157 + TB-500 combination community reports*peptides/glow-blend*— Wolverine + GHK-Cu (adds cosmetic/skin layer)*peptides/klow-blend*— Wolverine + GHK-Cu + KPV (full recovery + gut + inflammation)
Commercial note
TB-500 is available through Alyve — use code OHM-15 at checkout for 15% off.